BetterScholar BetterScholar
7
Role
Title
Level Year L/R
🦁 Current management of metastatic brain disease
T. Ranjan, L. Abrey
5 2009
5
🦁
🐜 Glioblastoma with PNET-like components has a higher frequency of isocitrate dehydrogenase 1 (IDH1) mutation and likely a better prognosis than primary glioblastoma.
11 auth. Xianyuan Song, R. Andrew Allen, S. Terence Dunn, K. Fung, P. Farmer, Shital Gandhi, ... T. Ranjan, A. Demopoulos, M. Symons, M. Schulder, Jian Yi Li
5 2011
5
🐜
🦁 Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial
25 auth. T. Ranjan, S. Sengupta, M. Glantz, Richard M. Green, A. Yu, D. Aregawi, R. Chaudhary, Ricky Chen, M. Zuccarello, C. Lu-Emerson, H. Moulding, N. Belman, J. Glass, A. Mammoser, Mark D. Anderson, ... J. Valluri, Nicholas Marko, J. Schroeder, S. Jubelirer, F. Chow, P. Claudio, A. Alberico, Seth T. Lirette, K. Denning, C. Howard
4 2023
4
🦁
🐬 Re-Irradiation with Stereotactic Radiosurgery/Radiotherapy for Recurrent High-Grade Gliomas: Improved Survival in the Modern Era
Michael J. Gigliotti, S. Hasan, S. Karlovits, T. Ranjan, R. Wegner
4 2018
4
🐬
🦁 Cancer Stem Cell Chemotherapeutics Assay for Prospective Treatment of Recurrent Glioblastoma and Progressive Anaplastic Glioma: A Single-Institution Case Seriesβ˜†
15 auth. T. Ranjan, C. Howard, A. Yu, Linda Xu, K. Aziz, D. Jho, Jodi Leonardo, Muhammad Hameed, S. Karlovits, R. Wegner, ... R. Fuhrer, Seth T. Lirette, K. Denning, J. Valluri, P. Claudio
4 2020
4
🦁
🐜 National trends in radiation dose escalation for glioblastoma
8 auth. R. Wegner, S. Abel, Z. Horne, S. Hasan, V. Verma, T. Ranjan, ... R. Williamson, S. Karlovits
4 2019
4
🐜
🐜 ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) IN RECURRENT GLIOBLASTOMA (GBM): FIRST PHASE I CLINICAL TRIAL EVALUATING THE INTRATUMORAL ADMINISTRATION
14 auth. A. Desjardins, J. Sampson, K. Peters, T. Ranjan, G. Vlahović, S. Threatt, J. Herndon, S. Boulton, Denise Lally-Goss, F. McSherry, ... A. Friedman, H. Friedman, D. Bigner, M. Gromeier
3 2014
3
🐜